For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Applications Segment:
- Oncology
- Cardiology
- Immunology
- Ophthalmology
- Genetic Diseases
- Neurology
- Regenerative Medicine
- Metabolic Diseases
Companies Covered:
- A2 Biotherapeutics
- Arsenal Biosciences
- Beam Therapeutics Inc.
- CRISPR Therapeutics AG
- Encoded Therapeutics Inc.
- ImmPACT Bio USA
- Intellia Therapeutics
- MeiraGTx Holdings plc
- Obsidian Therapeutics
- Strand Therapeutics Inc.
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- A2 Biotherapeutics
- Arsenal Biosciences
- Beam Therapeutics Inc.
- CRISPR Therapeutics AG
- Encoded Therapeutics Inc.
- ImmPACT Bio USA
- Intellia Therapeutics
- MeiraGTx Holdings plc
- Obsidian Therapeutics
- Strand Therapeutics Inc.
- Senti Bio

